Finance

Lists
DARE:NASDAQ
Dare Bioscience Inc
US$ ०.७७
-५.१८%
(-०.०४२) 1D
US$ ०.७६
-१.०५% (-०.००८१)
After hours
Closed: अगस्ट १८, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DARE...
Open
US$ ०.८२
High
US$ ०.८३
Low
US$ ०.७५
Mkt. cap
१.१७ करोड
Avg. vol.
७.०० लाख
Volume
०.००
52-wk high
US$ ३.७८
52-wk low
US$ ०.७५
EPS
-US$ १.०४
Beta
१.०८
Shares outstanding
१.५३ करोड
No. of employees
२१
Open
US$ ०.८२
High
US$ ०.८३
Low
US$ ०.७५
Mkt. cap
१.१७ करोड
Avg. vol.
७.०० लाख
Volume
०.००
52-wk high
US$ ३.७८
52-wk low
US$ ०.७५
EPS
-US$ १.०४
Beta
१.०८
Shares outstanding
१.५३ करोड
No. of employees
२१
News stories
From web sources and news partners
Stock Titan
Stock Titan
·
१६ घण्टा पहिले
Forbes puts a women's health biotech CEO on its 2026 innovation list
GuruFocus
GuruFocus
·
१ दिन पहिले
Dare Bioscience Inc (DARE) (Q2 2026) Earnings Call Highlights: C
TipRanks
TipRanks
·
१ दिन पहिले
Daré Bioscience Announces New Equity Financing Agreements
Investing.com
Investing.com
·
१ दिन पहिले
H.C. Wainwright reiterates Dare Bioscience stock rating at buy
About Dare Bioscience Inc
CEOSabrina Martucci Johnson
Employees२१
Founded२००५
Headquartersसान डिएगो, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websitedarebioscience.com
Analyst ratings
Based on 2 analysts giving stock ratings to DARE in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for DARE in the last 3 months.
Highest
Current US$ ०.७७
US$ १२.०० (+१,४६२.०९%)
Average
US$ १०.०० (+१,२०१.७४%)
Lowest
US$ ८.०० (+९४१.४०%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
US$ ८.००
+९४१.४%
08/14/2026
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
US$ १२.००
+१,४६२.१%
08/14/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२.२६ हजार
१०.२४ लाख
१.५२ लाख
१.८८ लाख
Cost of goods sold
११.७५ लाख
-४६.०६ लाख
९.०३ लाख
३.२० लाख
Cost of revenue
११.७५ लाख
-४६.०६ लाख
९.०३ लाख
३.२० लाख
Research and development expenses
-
५५.२३ लाख
-
२.४२ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२४.९९ लाख
१५.७७ लाख
२२.४९ लाख
२५.९४ लाख
Operating expense
२४.९९ लाख
७१.०० लाख
२२.४९ लाख
२८.३६ लाख
Total operating expenses
३६.७४ लाख
२४.९५ लाख
३१.५१ लाख
३१.५६ लाख
Operating income
-३६.७२ लाख
-१४.७१ लाख
-२९.९९ लाख
-२९.६८ लाख
Other non operating income
१.०९ लाख
२९.५५ हजार
-९९१.००
-१४.७९ हजार
EBT including unusual items
-३५.६३ लाख
-१४.४२ लाख
-३०.०० लाख
-२९.८३ लाख
EBT excluding unusual items
-३५.६३ लाख
-१४.४२ लाख
-३०.०० लाख
-२९.८३ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-३५.६३ लाख
-१४.४२ लाख
-३०.०० लाख
-२९.८३ लाख
Net profit margin
-१,५७,५०५.१३%
-१४०.८४%
-१,९६७.७२%
-१,५९०.४२%
Earnings per share
-०.२८
-०.१०
-०.२०
-०.२०
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-३१.९० लाख
-९.३७ लाख
-२४.४४ लाख
-२३.९६ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू